GTHX

G1 Therapeutics, Inc. Common Stock

Delisted

GTHX was delisted on the 17th of September, 2024.

94 hedge funds and large institutions have $741M invested in G1 Therapeutics, Inc. Common Stock in 2018 Q1 according to their latest regulatory filings, with 42 funds opening new positions, 37 increasing their positions, 11 reducing their positions, and 4 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
94
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
Puts
Net Calls
Net Calls Change

Top Buyers

1 +$45.3M
2 +$41.3M
3 +$27.4M
4
BlackRock
BlackRock
New York
+$19.8M
5
Capital World Investors
Capital World Investors
California
+$17.6M

Top Sellers

1 -$8.44M
2 -$6.58M
3 -$4.44M
4
EA
Emerald Advisers
Pennsylvania
-$705K
5
Goldman Sachs
Goldman Sachs
New York
-$299K
Name Holding Trade Value Shares
Change
Change in
Stake
26
$3.13M
27
$2.93M
28
$2.55M
29
$2.52M
30
$1.84M
31
$1.74M
32
$1.57M
33
$1.48M
34
$1.48M
35
$1.42M
36
$1.41M
37
$1.41M
38
$1.31M
39
$1.31M
40
$1.26M
41
$1.19M
42
$1.14M
43
$1.14M
44
$1.07M
45
$1.06M
46
$1.01M
47
$957K
48
$911K
49
$815K
50
$762K